Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial.

Abstract

BACKGROUND AND AIMS It has been suggested that magnesium deficiency is associated with the triggering of acute phase response, which may contribute to type 2 diabetes and cardiovascular disease risk. We undertook this study to determine whether oral magnesium supplementation modifies serum levels of high-sensitivity C-reactive protein (hsCRP) in apparently… (More)
DOI: 10.1016/j.arcmed.2014.04.006

Topics

Cite this paper

@article{SimentalMenda2014OralMS, title={Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial.}, author={Luis E Simental-Mend{\'i}a and Martha Rodr{\'i}guez-Mor{\'a}n and Fernando Guerrero-Romero}, journal={Archives of medical research}, year={2014}, volume={45 4}, pages={325-30} }